Viewing Study NCT02891551


Ignite Creation Date: 2025-12-24 @ 11:52 PM
Ignite Modification Date: 2026-01-19 @ 6:48 PM
Study NCT ID: NCT02891551
Status: COMPLETED
Last Update Posted: 2019-07-24
First Post: 2015-10-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: An Observational Post Authorisation Study to Evaluate Safety and Efficacy in Patients Receiving Azacitidine in Daily Clinical Practice in the Netherlands
Sponsor: Celgene
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module